Citius Oncology, Inc. CTOR Adjustments To Additional Paid In Capital December2025Offering Costs
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:AdjustmentsToAdditionalPaidInCapitalDecember2025OfferingCosts.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s adjustments to additional paid in capital december2025offering costs.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s adjustments to additional paid in capital december2025offering costs?
- Citius Oncology, Inc. (CTOR) reported adjustments to additional paid in capital december2025offering costs of -$62.77K in Q1 2026.